Stephen A. Hurly
Chief Executive Officer · LAVA Therapeutics NV
Individual
- 2025
- Nov 17, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Stephen A. Hurly. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Versant Venture Capital VI, L.P. - $6.57M in LVTX purchases and sales on record
- Gilde Healthcare Iv U.A. Cooperatieve - $5.14M in LVTX purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephen A. Hurly?
Stephen A. Hurly is a corporate insider, tracked as Chief Executive Officer of LAVA Therapeutics NV (LVTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Stephen A. Hurly last file a Form 4?
The only primary Form 4 on record is dated 17 November 2025.
